BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 38735821)

  • 1. Reply to Ping Zhong, Xin Liu, and Limin Liao's Letter to the Editor re: Michele Gnech, Lisette 't Hoen, Alexandra Zachou, et al. Update and Summary of the European Association of Urology/European Society of Paediatric Urology Paediatric Guidelines on Vesicoureteral Reflux in Children. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2023.12.005.
    Gnech M; 't Hoen L; Burgu B; Radmayr C
    Eur Urol; 2024 May; ():. PubMed ID: 38735821
    [No Abstract]   [Full Text] [Related]  

  • 2. Re: Michele Gnech, Lisette 't Hoen, Alexandra Zachou, et al. Update and Summary of the European Association of Urology/European Society of Paediatric Urology Paediatric Guidelines on Vesicoureteral Reflux in Children. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2023.12.005.
    Zhong P; Liu X; Liao L
    Eur Urol; 2024 Apr; ():. PubMed ID: 38614821
    [No Abstract]   [Full Text] [Related]  

  • 3. Reply to Meny Lv, Xufei Luo, and Yaolong Chen's Letter to the Editor re: Mauro Gacci, Vasileios I. Sakalis, Markos Karavitakis, et al. European Association of Urology Guidelines on Male Urinary Incontinence. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2022.05.012.
    Gacci M; Sakalis VI; Karavitakis M; Gravas S
    Eur Urol; 2022 Oct; 82(4):e119-e120. PubMed ID: 35945088
    [No Abstract]   [Full Text] [Related]  

  • 4. Re: Börje Ljungberg, Laurence Albiges, Yasmin Abu-Ghanem, et al. European Association of Urology Guidelines on Renal Cell Carcinoma: The 2022 Update. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2022.03.006.
    Wei Y; Zhang R; Lin L
    Eur Urol; 2022 Sep; 82(3):e88. PubMed ID: 35750581
    [No Abstract]   [Full Text] [Related]  

  • 5. Re: Mauro Gacci, Vasileios I. Sakalis, Markos Karavitakis, et al. European Association of Urology Guidelines on Male Urinary Incontinence. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2022.05.012.
    Lv M; Luo X; Chen Y
    Eur Urol; 2022 Oct; 82(4):e118. PubMed ID: 35961869
    [No Abstract]   [Full Text] [Related]  

  • 6. Reply to Emre Karabay and İlker Tınay's Letter to the Editor re: Treatment of High-grade Non-muscle-invasive Bladder Carcinoma by Standard Number and Dose of BCG Instillations Versus Reduced Number and Standard Dose of BCG Instillations: Results of the European Association of Urology Research Foundation Randomised Phase III Clinical Trial "NIMBUS". Eur Urol. In press. https://doi.org/10.1016/j.eururo.2020.04.066.
    Grimm MO; Caris C; Witjes WPJ;
    Eur Urol; 2020 Oct; 78(4):e163-e164. PubMed ID: 32693930
    [No Abstract]   [Full Text] [Related]  

  • 7. Reply to Jianhui Du, Yueguang Liu, and Weigang Yan's Letter to the Editor re: Gregory T. Chesnut, Emily A. Vertosick, Nicole Benfante, et al. Role of Changes in Magnetic Resonance Imaging or Clinical Stage in Evaluation of Disease Progression for Men with Prostate Cancer on Active Surveillance. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2019.12.009.
    Chesnut GT; Vertosick EA; Ehdaie B
    Eur Urol; 2020 Aug; 78(2):e65-e66. PubMed ID: 32386781
    [No Abstract]   [Full Text] [Related]  

  • 8. Re: Maria J. Ribal, Philip Cornford, Alberto Briganti, et al. European Association of Urology Guidelines Office Rapid Reaction Group: An Organisation-wide Collaborative Effort to Adapt the European Association of Urology Guidelines Recommendations to the Coronavirus Disease 2019 Era. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2020.04.056: Metastatic Prostate Cancer and COVID-19: Do Current Data Allow Modification of Established Treatment Recommendations?
    Thomas C; Grüllich C; Erb HHH
    Eur Urol Focus; 2020 Sep; 6(5):1135-1136. PubMed ID: 32534970
    [No Abstract]   [Full Text] [Related]  

  • 9. Reply to Andrew J. Vickers' Letter to the Editor re: Michael Baboudjian, Romain Diamand, Alessandro Uleri, et al. Does Overgrading on Targeted Biopsy of Magnetic Resonance Imaging-visible Lesions in Prostate Cancer Lead to Overtreatment? Eur Urol. In press. https://doi.org/10.1016/j.eururo.2024.02.003.
    Uleri A; Baboudjian M; Diamand R; Ploussard G
    Eur Urol; 2024 May; ():. PubMed ID: 38796380
    [No Abstract]   [Full Text] [Related]  

  • 10. Reply to Jinna Yao, Henry C.C. Pleass, and Howard M.H. Lau's Letter to the Editor re: Andrea Gallioli, Angelo Territo, Romain Boissier, et al. Learning Curve in Robot-assisted Kidney Transplantation: Results from the European Robotic Urological Society Working Group. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2019.12.008.
    Gallioli A; Territo A; Breda A
    Eur Urol; 2020 Jun; 77(6):e166-e167. PubMed ID: 32291108
    [No Abstract]   [Full Text] [Related]  

  • 11. Reply to Behnam Shakiba's Letter to the Editor re: Emilien Seizilles de Mazancourt, Juliette Cotte, Caroline Plassais, et al. Sexual and Moral Harassment of French Urologists in Training and Barriers to Reporting: Results from a National Survey. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2023.10.020.
    Seizilles de Mazancourt E; Kaulanjan K
    Eur Urol; 2024 Feb; ():. PubMed ID: 38388257
    [No Abstract]   [Full Text] [Related]  

  • 12. Reply to Mattias Höglund's Letter to the Editor re: Alexander Cox, Niklas Klümper, Johannes Stein, et al. Molecular Urothelial Tumor Cell Subtypes Remain Stable During Metastatic Evolution. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2023.03.020.
    Klümper N; Cox A; Eckstein M
    Eur Urol; 2023 Aug; 84(2):e51-e52. PubMed ID: 37244816
    [No Abstract]   [Full Text] [Related]  

  • 13. Reply to Ryan S. Hsi, John M. Hollingsworth, and Tatuki Koyama's Letter to the Editor re: Lazaros Tzelves, Robert Geraghty, Riccardo Lombardo, et al. Duration of Follow-up and Timing of Discharge from Imaging Follow-up, in Adult Patients with Urolithiasis After Surgical or Medical Intervention: A Systematic Review and Meta-analysis from the European Association of Urology Guideline Panel on Urolithiasis. Eur Urol Focus. In press. https://doi.org/10.1016/j.euf.2022.06.016.
    Tzelves L; Geraghty R; Lombardo R; Davis NF; Petřík A; Neisius A; Gambaro G; Türk C; Thomas K; Somani B; Skolarikos A
    Eur Urol Focus; 2023 Mar; 9(2):381-382. PubMed ID: 36184536
    [No Abstract]   [Full Text] [Related]  

  • 14. Reply to Kentaro Inamura's Letter to the Editor re: Mingxiao Feng, Andres Matoso, Gabriel Epstein, et al. Identification of Lineage-specific Transcriptional Factor-defined Molecular Subtypes in Small Cell Bladder Cancer. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2023.05.023.
    Feng M; Matoso A; Epstein G; Fong M; Park YH; Gabrielson A; Patel S; Czerniak B; Compérat E; Hoffman-Censits J; Kates M; Kim S; McConkey D; Choi W
    Eur Urol; 2024 Apr; 85(4):e122-e123. PubMed ID: 37775361
    [No Abstract]   [Full Text] [Related]  

  • 15. Reply to Hein V. Stroomberg, Klaus Brasso, and Andreas Røder's Letter to the Editor re: Michael Baboudjian, Romain Diamand, Alessandro Uleri, et al. Does Overgrading on Targeted Biopsy of Magnetic Resonance Imaging-visible Lesions in Prostate Cancer Lead to Overtreatment? Eur Urol. In press. https://doi.org/10.1016/j.eururo.2024.02.003.
    Uleri A; Baboudjian M; Diamand R; Ploussard G
    Eur Urol; 2024 May; ():. PubMed ID: 38796382
    [No Abstract]   [Full Text] [Related]  

  • 16. Reply to Ilias Giannakodimos' Letter to the Editor re: Jim C. Hu, Melissa Assel, Mohamad E. Allaf, et al. Transperineal Versus Transrectal Magnetic Resonance Imaging-targeted and Systematic Prostate Biopsy to Prevent Infectious Complications: The PREVENT Randomized Trial. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2023.12.015.
    Hu JC; Schaeffer EM; Vickers AJ
    Eur Urol; 2024 Apr; ():. PubMed ID: 38670878
    [No Abstract]   [Full Text] [Related]  

  • 17. Reply to Kamal Kant Sahu's Letter to the Editor re: Veerle H. Groen, Karin Haustermans, Floris J. Pos, et al. Patterns of Failure Following External Beam Radiotherapy With or Without an Additional Focal Boost in the Randomized Controlled FLAME Trial for Localized Prostate Cancer. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2021.12.012.
    Kerkmeijer LGW; Pos FJ; van der Heide UA; Israël B; Draulans C; Haustermans K
    Eur Urol; 2022 Jun; 81(6):e147-e148. PubMed ID: 35339319
    [No Abstract]   [Full Text] [Related]  

  • 18. Reply to Giancarlo Marra, Marco Oderda, Paolo Gontero, and Lorenzo Richiardi's Letter to the Editor re: Jim C. Hu, Melissa Assel, Mohamad E. Allaf, et al. Transrectal Magnetic Resonance Imaging-targeted and Systematic Prostate Biopsy to Prevent Infectious Complications: The PREVENT Randomized Trial. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2023.12.015.
    Hu JC; Allaf ME; Vickers AJ; Schaeffer EM
    Eur Urol; 2024 Apr; ():. PubMed ID: 38599991
    [No Abstract]   [Full Text] [Related]  

  • 19. Reply to Yudai Ishiyama and Fumihiko Urabe's Letter to the Editor re: Kosuke Takemura, Audreylie Lemelin, Matthew S. Ernst, et al. Outcomes of Patients with Brain Metastases from Renal Cell Carcinoma Receiving First-line Therapies: Results from the International Metastatic Renal Cell Carcinoma Database Consortium. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2024.01.006.
    Takemura K; Yuasa T; Choueiri TK; Heng DYC
    Eur Urol; 2024 Mar; ():. PubMed ID: 38531704
    [No Abstract]   [Full Text] [Related]  

  • 20. Reply to Shun-Fa Hung, Shyi-Chun Yii, and Shiu-Dong Chung's Letter to the Editor re: Zhiwen Chen, Peng He, Xiaozhou Zhou, et al. Preliminary Functional Outcome Following Robotic Intracorporeal Orthotopic Ileal Neobladder Suspension with Round Ligaments in Women with Bladder Cancer. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2021.11.012.
    He P; Zhou X; Chen Z
    Eur Urol; 2022 May; 81(5):e119. PubMed ID: 35125227
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.